» Articles » PMID: 19630799

The Y's That Bind: Negative Regulators of Src Family Kinase Activity in Platelets

Overview
Publisher Elsevier
Specialty Hematology
Date 2009 Jul 28
PMID 19630799
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Members of the Src family of protein tyrosine kinases play important roles in platelet adhesion, activation, and aggregation. The purpose of this review is to summarize current knowledge regarding how Src family kinase activity is regulated in general, to describe what is known about mechanisms underlying SFK activation in platelets, and to discuss platelet proteins that contribute to SFK inactivation, particularly those that use phosphotyrosine-containing sequences to recruit phosphatases and kinases to sites of SFK activity.

Citing Articles

Characterization of Integrin αIIbβ3-Mediated Outside-in Signaling by Protein Kinase Cδ in Platelets.

Chaudhary P, Kim S, Jee Y, Lee S, Kim S Int J Mol Sci. 2020; 21(18).

PMID: 32911704 PMC: 7555476. DOI: 10.3390/ijms21186563.


Impaired Glycoprotein VI-Mediated Signaling and Platelet Functional Responses in CD45 Knockout Mice.

Inamdar V, Kostyak J, Badolia R, Dangelmaier C, Manne B, Patel A Thromb Haemost. 2019; 119(8):1321-1331.

PMID: 31226719 PMC: 7192241. DOI: 10.1055/s-0039-1692422.


PKC and AKT Modulate cGMP/PKG Signaling Pathway on Platelet Aggregation in Experimental Sepsis.

Lopes-Pires M, Naime A, Almeida Cardelli N, Anjos D, Antunes E, Marcondes S PLoS One. 2015; 10(9):e0137901.

PMID: 26375024 PMC: 4573322. DOI: 10.1371/journal.pone.0137901.


Immunoreceptor tyrosine-based inhibitory motif (ITIM)-mediated inhibitory signaling is regulated by sequential phosphorylation mediated by distinct nonreceptor tyrosine kinases: a case study involving PECAM-1.

Tourdot B, Brenner M, Keough K, Holyst T, Newman P, Newman D Biochemistry. 2013; 52(15):2597-608.

PMID: 23418871 PMC: 3666314. DOI: 10.1021/bi301461t.


Safety and efficacy of bosutinib (SKI-606) in chronic phase Philadelphia chromosome-positive chronic myeloid leukemia patients with resistance or intolerance to imatinib.

Cortes J, Kantarjian H, Brummendorf T, Kim D, Turkina A, Shen Z Blood. 2011; 118(17):4567-76.

PMID: 21865346 PMC: 4916618. DOI: 10.1182/blood-2011-05-355594.


References
1.
Boylan B, Berndt M, Kahn M, Newman P . Activation-independent, antibody-mediated removal of GPVI from circulating human platelets: development of a novel NOD/SCID mouse model to evaluate the in vivo effectiveness of anti-human platelet agents. Blood. 2006; 108(3):908-14. PMC: 1895852. DOI: 10.1182/blood-2005-07-2937. View

2.
Chong Y, Ia K, Mulhern T, Cheng H . Endogenous and synthetic inhibitors of the Src-family protein tyrosine kinases. Biochim Biophys Acta. 2005; 1754(1-2):210-20. DOI: 10.1016/j.bbapap.2005.07.027. View

3.
Sicheri F, Kuriyan J . Structures of Src-family tyrosine kinases. Curr Opin Struct Biol. 1998; 7(6):777-85. DOI: 10.1016/s0959-440x(97)80146-7. View

4.
Rathore V, Okada M, Newman P, Newman D . Paxillin family members function as Csk-binding proteins that regulate Lyn activity in human and murine platelets. Biochem J. 2007; 403(2):275-81. PMC: 1874248. DOI: 10.1042/BJ20061618. View

5.
Nika K, Tautz L, Arimura Y, Vang T, Williams S, Mustelin T . A weak Lck tail bite is necessary for Lck function in T cell antigen receptor signaling. J Biol Chem. 2007; 282(49):36000-9. DOI: 10.1074/jbc.M702779200. View